re: cst and pgl, 2 gravy trains running? I did inform quite a few people when PGL was $1.50 in Jan.
The Options have gone up by 700% or so.
It is a very sophisticated drug, possibly better than AVASTIN.
_________________________
From Pa2000
"The note's from eG Capital.
They comment on Q3 Avastin sales, the relevence for PGL and how conservative their current valuation is (A$6.15).
They highlight as conservative assumptions:
- the deal size (US$100m);
- the drug price (half that of Avastin);
- the royalty rate (8%);
- no value on PI-166;
- no value on Medigen holding;
- no value on other IP (2nd generation PI-88, heparanase products, etc).
The A$16.90 valuation is simply the "unrisked" version (i.e. the drug making it to market) of the A$6.15 one (which discounts royalty revenues by 60% and total valuation by 20% to account for the risk of PI-88 not making it).
Can only imagine what it would look like if they weren't so conservative!"
PA
_____________________
- Forums
- ASX - By Stock
- CST
- cst and pgl: 2 gravy trains running?
cst and pgl: 2 gravy trains running?, page-8
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.41M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 226091 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 15337 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 226091 | 0.072 |
1 | 200000 | 0.071 |
3 | 230000 | 0.070 |
1 | 8475 | 0.059 |
1 | 13000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 15337 | 1 |
0.079 | 29850 | 1 |
0.080 | 32000 | 2 |
0.082 | 11000 | 1 |
0.084 | 8500 | 1 |
Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable